03/02/2020 Merck has received approval from the FDA to expand indication for suvorexant for the treatment of insomnia in people with mild to moderate AD dementia Science watch
29/01/2020 Researchers investigate the possible relationship between flavonols and risk of Alzheimer’s dementia Science watch
28/01/2020 Alector announces the recruitment of the first participants with mild to moderate AD in Phase Ib trial of AL003 Science watch
28/01/2020 Biogen receives approval from FDA to relaunch a Phase III clinical trial of Aducanumab Science watch
27/01/2020 Corium announces FDA filling acceptance for Adlarity for the treatment of AD Science watch
23/01/2020 Clinical study finds no association between herpesvirus and Alzheimer’s disease Science watch
22/01/2020 Neurotrope reports results from its Phase II trial of Bryostatin-1 for moderate to severe AD Science watch
21/01/2020 Study in AD rats reveals functional benefit of lithium microdosing at later stages of amyloid pathology Science watch
15/01/2020 Computer tool created to help doctors identify which patients would benefit from CSF tests during diagnostic process for AD Science watch
13/01/2020 Biogen acquires Pfizer’s experimental drug PF-05251749 for neurological diseases Science watch
08/01/2020 Clinical study shows that an active lifestyle can slow cognitive decline in people with inherited forms of frontotemporal dementia Science watch
08/01/2020 Research study suggests that a class of antibiotics may help treat frontotemporal dementia Science watch
